Published in Drug Alcohol Depend on November 02, 2010
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol Rev (2013) 1.03
Internet addictive individuals share impulsivity and executive dysfunction with alcohol-dependent patients. Front Behav Neurosci (2014) 0.86
Active Ingredients of Treatment and Client Mechanisms of Change in Behavioral Treatments for Alcohol Use Disorders: Progress 10 Years Later. Alcohol Clin Exp Res (2015) 0.85
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs (2011) 0.80
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder. J Subst Abuse Treat (2015) 0.78
Depression CBT treatment gains among HIV-infected persons with a history of injection drug use varies as a function of baseline substance use. Psychol Health Med (2015) 0.78
New developments in behavioral treatments for substance use disorders. Curr Psychiatry Rep (2013) 0.77
Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression. J Consult Clin Psychol (2014) 0.76
Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence. Drug Alcohol Depend (2012) 0.76
Distinct facets of impulsivity exhibit differential associations with substance use disorder treatment processes: a cross-sectional and prospective investigation among military veterans. J Subst Abuse Treat (2015) 0.75
Brain structural substrates of cognitive procedural learning in alcoholic patients early in abstinence. Alcohol Clin Exp Res (2014) 0.75
Performance-Based Contingency Management in Cognitive Remediation Training: A Pilot Study. J Subst Abuse Treat (2016) 0.75
Atomoxetine in abstinent cocaine users: Sex differences. Data Brief (2017) 0.75
Factor structure of the Barratt impulsiveness scale. J Clin Psychol (1995) 19.86
Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods. Multivariate Behav Res (2004) 16.08
Mediation analysis. Annu Rev Psychol (2007) 15.45
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34
Distribution of the product confidence limits for the indirect effect: program PRODCLIN. Behav Res Methods (2007) 10.09
On the practice of dichotomization of quantitative variables. Psychol Methods (2002) 9.18
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl (2002) 7.26
Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol (1992) 6.92
Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol (2004) 5.35
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. J Abnorm Psychol (1992) 3.46
Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction (2000) 3.25
Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours. J Adolesc (2003) 2.76
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat (2001) 2.48
Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend (2003) 2.10
Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol (2005) 2.05
Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci (2004) 1.96
Theory-based active ingredients of effective treatments for substance use disorders. Drug Alcohol Depend (2006) 1.86
Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry (1994) 1.81
Normative data and a short form of the Barratt Impulsiveness Scale. Int J Neurosci (2007) 1.78
Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol Addict Behav (2008) 1.72
Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav (2006) 1.69
Speed and memory in the WAIS-III Digit Symbol--Coding subtest across the adult lifespan. Arch Clin Neuropsychol (2004) 1.55
Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend (2007) 1.44
Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol Addict Behav (2006) 1.41
Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse (1992) 1.39
Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation. J Consult Clin Psychol (1993) 1.35
Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction (2010) 1.32
Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults. Drug Alcohol Depend (2004) 1.32
Matching alcoholics to coping skills or interactional therapies: posttreatment results. J Consult Clin Psychol (1989) 1.26
Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav (2005) 1.24
Changes in alcoholic patients' coping responses predict 12-month treatment outcomes. J Consult Clin Psychol (2001) 1.21
Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend (2008) 1.16
Behavioral assessment of impulsivity in pathological gamblers with and without substance use disorder histories versus healthy controls. Drug Alcohol Depend (2009) 1.13
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12
Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. J Stud Alcohol (1999) 1.11
Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug Alcohol Depend (2008) 0.97
Cognitive impairment in substance abuse. Psychiatr Clin North Am (2004) 0.96
Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence. Psychiatry Res (2008) 0.95
Clinical limitations of neuropsychological testing in predicting treatment outcome among alcoholics. Alcohol Clin Exp Res (1984) 0.90
Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. J Psychoactive Drugs (1989) 0.85
Cognitive functioning and treatment outcome in alcoholics. J Nerv Ment Dis (1990) 0.84
The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. Exp Clin Psychopharmacol (2004) 0.82
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry (2004) 3.72
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend (2003) 3.19
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction (2004) 3.06
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend (2008) 2.33
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol (2006) 2.31
Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend (2008) 2.06
Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem (2009) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. J Consult Clin Psychol (2006) 1.98
Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry (2014) 1.93
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (2012) 1.93
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry (2005) 1.82
A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. J Consult Clin Psychol (2009) 1.69
Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend (2011) 1.68
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos (2003) 1.66
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50
Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res (2009) 1.49
Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend (2002) 1.45
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol (2002) 1.44
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Mol Immunol (2010) 1.38
Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36
A cognitive behavioral therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV). Am J Addict (2007) 1.33
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction (2010) 1.32
A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol (2012) 1.32
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
One small step for manuals: Computer-assisted training in twelve-step facilitation. J Stud Alcohol (2006) 1.29
The cost-effectiveness of four treatments for marijuana dependence. Addiction (2007) 1.29
D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend (2009) 1.27
Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial. Am J Addict (2003) 1.27
A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am J Psychiatry (2011) 1.26
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug Alcohol Depend (2009) 1.20
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction (2010) 1.20
A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2011) 1.18
Practice makes progress? Homework assignments and outcome in treatment of cocaine dependence. J Consult Clin Psychol (2005) 1.17
Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Am J Addict (2002) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry (2005) 1.15
Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction (2010) 1.12
Tailoring cannabis dependence treatment for a diverse population. Addiction (2002) 1.12
The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems. Psychol Addict Behav (2002) 1.12
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12
A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction (2006) 1.11
Contingency Management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse (2007) 1.10
Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend (2010) 1.10
Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project. Psychiatry Res (2010) 1.10
Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav (2010) 1.10
Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Psychiatr Serv (2004) 1.10
Issues in designing and implementing a Spanish-language multi-site clinical trial. Am J Addict (2007) 1.09
Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat (2013) 1.08
Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction (2012) 1.08
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08
Mutual influence in therapist competence and adherence to motivational enhancement therapy. Drug Alcohol Depend (2011) 1.08
Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychol Addict Behav (2012) 1.08
White matter integrity is associated with treatment outcome measures in cocaine dependence. Neuropsychopharmacology (2010) 1.07
Evidence-based practices for substance use disorders. Psychiatr Clin North Am (2003) 1.05
A criterion-based stepwise approach for training counselors in motivational interviewing. J Subst Abuse Treat (2011) 1.05
Cost and cost-effectiveness of three strategies for training clinicians in motivational interviewing. Drug Alcohol Depend (2011) 1.04
Technology-based interventions for the treatment and recovery management of substance use disorders: a JSAT special issue. J Subst Abuse Treat (2013) 1.03
Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users. Drug Alcohol Depend (2007) 1.01
The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav (2012) 1.01
Construct, concurrent and predictive validity of the URICA: data from two multi-site clinical trials. Drug Alcohol Depend (2009) 0.98
Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry (2006) 0.98